India this Friday surpassed the barrier of 400,000 deaths by coronavirus when registering 853 deaths in the last 24 hours, one of the lowest figures in recent weeks after the second wave that caused a health collapse in the country, as well as a shortage of beds and oxygen.
The Asian country adds 400,312 deaths since the beginning of the pandemic, according to the latest data from the Indian Ministry of Health, and it became the third country in the world to overcome this barrier, behind the United States (605,013 deaths, according to Johns Hopkins University) and Brazil (520,095 deaths ).
India also registered 46,617 cases of Covid-19 in the last day, raising the total of infections to 30.4 million.
Infections in the Asian giant stagnated in recent days around the 40,000 daily, while deaths experienced a rapid decline in the last month.
India experienced a violent second wave of the coronavirus that reached its peak in mid-May with more than 400,000 cases and 4,000 deaths a day, putting a strain on their health system and leaving dramatic images of overcrowded hospitals and crematoriums.
The Delta variant virus, originally identified in India and which, according to the World Health Organization (WHO), already circulates in almost a hundred countries, is seen as one of the factors that contributed to the increase in cases in the Asian country due to its high transmissibility.
The vaccination program is seen by the Indian authorities as the main way out of the crisis, although the dose shortage slowed down government plans.
The country administered 4.2 million doses in the last 24 hours, bringing the total number of inoculations to 340 million since the beginning of the campaign last January.
This figure supposes a decrease compared to the record of more than 8 million doses administered in a single day, on Monday of last week.
The country authorized the emergency use of Moderna’s vaccine this week, in addition to AstraZeneca’s Covishield, which is produced thanks to an agreement with the Serum Institute of India (SII), the indigenous Covaxin, from the Indian laboratory Bharat Biotech. , and the Russian formula Sputnik V.
With information EFE.